Get started
Award

#ALFGBG-715986

Funded outputs count: 331
Funder award ID: #ALFGBG-715986
OpenAlex ID: G2841269746
Spatiotemporal characterization of Alzheimer disease pathology in living human brain tissue
2026 · Aram Aslanyan, Soumya Mukherjee, et al. · Nature Communications · 1
PDF
CSF p-tau205: a biomarker of Alzheimer’s disease progression and biological staging
2026 · Juan Lantero-Rodriguez, Shorena Janelidze, et al. · Molecular Psychiatry
PDF
Astrocyte reactivity modifies the effects of locus coeruleus norepinephrine‐related dysfunction on tau and its impact on cognition
2026 · Prokopis C. Prokopiou, Maxime Van Egroo, et al. · Alzheimer s & Dementia
Cerebrospinal fluid NPTX2/p‐tau ratio as a biomarker for cognitive decline in neurodegenerative diseases
2026 · Bárbara Fernandes Gomes, Mathias Sauer, et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 1
Aβ-related Cerebrospinal Fluid Proteins in Alzheimer’s Disease Reflect Gene Expression Levels Found in The Healthy Cortex
2026 · Pedro Rosa-Neto, Seyyed Ali Hosseini, et al. · Research Square
PDF
Physical activity across the life course and neural biomarkers
2026 · Elisa R. Torres, Eloise D. Lopez, et al. · Journal of Alzheimer s Disease
Biomarker-integrated prognostic stagings for Alzheimer’s Disease
2026 · Daeun Shin, Sungjoo Lee, et al. · Nature Communications · 6
PDF
Glymphatic dysfunction links vascular pathology to Alzheimer’s biomarkers and cognitive decline
2026 · Sung Hoon Kang, Seongmi Kim, et al. · Alzheimer s Research & Therapy · 9
Early functional changes and plasma GFAP in Swedish families with Autosomal Dominant Alzheimer’s disease mutations
2026 · Emma S. Luckett, Mariola Zapater-Fajari, et al. · Translational Psychiatry · 1
PDF
Plasma p-tau212 identifies cognitively unimpaired individuals with emerging amyloid-β pathology
2025 · Przemysław R. Kac, Armand González-Escalante, et al. · Journal of Neurology · 4
PDF
Association of acute blood biomarkers with diffusion tensor imaging and outcome in patients with traumatic brain injury presenting with GCS of 13–15
2025 · Malla Mononen, Mehrbod Mohammadian, et al. · NeuroImage Clinical · 2
Integrative analysis of AT classification, plasma biomarkers, and cognitive trajectories across diverse dementia syndromes
2025 · Jihwan Yun, Min Young Chun, et al. · Scientific Reports · 1
PDF
Saliva phosphorylated tau concentration is not associated with Alzheimer’s disease, cerebrospinal fluid or blood biomarkers
2025 · Helena Sophia Gleerup, Federica Sanna, et al. · Frontiers in Neuroscience · 2
PDF
APOE ɛ4 carriership determines a faster plasma p‐tau217 progression in Aβ‐positive individuals
2025 · Marcel S. Woo, Arthur C Macedo, et al. · Alzheimer s & Dementia · 4
Cerebrospinal fluid markers link to synaptic plasticity responses and Alzheimer’s disease genetic pathways
2025 · Bjørn-Eivind Kirsebom, Johanna Nilsson, et al. · Molecular Neurodegeneration · 6
PDF
Cerebrospinal fluid proteomic associations of APOE genotypes reveal distinct protective and risk mechanisms for Alzheimer's disease
2025 · Eleonora M. Vromen, Senne B. Lageman, et al. · Alzheimer s & Dementia · 8
PDF
Predicting cognitive decline with amyloid‐PET, plasma p‐tau217, Aβ42/40, and p‐tau217/Aβ42 in a community‐based cohort – relevance for clinical trial enrollment
2025 · Dario Bachmann, Maha Wybitul, et al. · Alzheimer s & Dementia · 5
PDF
Method comparison of plasma and CSF GFAP immunoassays across multiple platforms
2025 · Burak Arslan, Elzbieta Rembeza, et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 10
PDF
Isotope-encoded spatial biology identifies plaque-age-dependent maturation and synaptic loss in an Alzheimer’s disease mouse model
2025 · Jack I. Wood, Maciej Dulewicz, et al. · Nature Communications · 14
Prognostic Value of A/T/N Biomarkers: Comparing Plasma and Imaging Modalities in Alzheimer Disease
2025 · Sohyun Yim, Yuna Gu, et al. · Clinical Nuclear Medicine · 2
CSF total tau as a proxy of synaptic degeneration
2025 · Carolina Soares, Bruna Bellaver, et al. · Nature Communications · 20
PDF
The association of umbilical cord blood neurofilament light with non‐reassuring fetal status: A prospective observational study
2025 · David Zalcberg, Kaitlin Kramer, et al. · International Journal of Gynecology & Obstetrics · 2
PDF
Validation of a plasma GFAP immunoassay and establishment of age-related reference values: bridging analytical performance and routine implementation
2025 · Burak Arslan, Ulf Andreasson, et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 9
PDF
Plasma phosphorylated tau 217 and amyloid‑β 42/40 for amyloid risk in subgroups
2025 · Heekyoung Kang, Heejin Yoo, et al. · Alzheimer s Research & Therapy · 16
PDF
Plasma tau biomarkers are distinctly associated with tau tangles and decreased with Lewy body pathology
2025 · Laia Montoliu‐Gaya, Elizabeth Valeriano‐Lorenzo, et al. · Alzheimer s & Dementia · 11
PDF